Real-World Data Solutions

Unlocking real-world insights for transformative clinical outcomes

Citeline has a vast, integrated real-world data asset covering over 300 million patient lives. This data can be analyzed and triangulated to provide meaningful insights for early clinical development strategy planning, protocol optimization, site and investigator selection, and patient engagement. Using longitudinal transaction-level patient data and live lab test results, biomarkers and genomics data from our growing network of leading national reference labs, hospitals and health systems, we can identify unmet medical needs, detect patients at risk for disease earlier, and surface healthcare organizations (HCOs)/healthcare professionals (HCPs) treating protocol-matched patients.

Aerial shot of a diverse population, key to the success of the Diversity Action Plan.

Take a patient-centric view

Leverage a continuously updated, integrated, tokenized real-world data asset stemming from:

Medical claims and lab test/results data (including biomarkers and genomics)
Global electronic health records (EHRs)
Census and CMS data
And more

With real-world data, you can:

Derive actionable insights that span diagnoses, prescriptions, procedures, treatment and referral patterns, outcomes, safety profiles, and comparative effectiveness
Consider patient demographics and social determinants of health (SDOH) to design more equitable and diverse clinical programs and trials
Accelerate your clinical trial enrollment by selecting sites and investigators with high volumes of the right patients

How RWD helps with clinical trial planning & execution

Early clinical development planning & strategy

Creating a comprehensive development strategy requires answers to complex questions that are best served by RWD. Identify unmet medical needs within diseases/diagnoses, size market opportunities, or pinpoint gaps in today’s therapies to differentiate your asset and clinical program endpoints.

Protocol design and patient population impact

Crafting a clinical trial protocol that is scientifically rigorous and operationally feasible is no small feat. Using RWD, Citeline can analyze your protocol design iterations to show impact on eligible patient populations and help you find a balance in your eligibility that works — on paper and in real life.

Site and principal investigator selection

Select the best sites and investigators for your trial by shortlisting with those with the highest volume of potentially eligible patients for your trial — aka, protocol-matched patients — in addition to the right experience, availability, and other insights gleaned from Trialtrove and Sitetrove.

Patient engagement

Once you’ve identified HCPs treating patients that match your protocol, tap into Citeline Connect services for outreach to support recruitment. Raise awareness about your clinical trial with HCPs who have direct, confirmed access to potential participants.

How it works

We understand that every client has unique requirements and objectives. That's why we offer fully customizable solutions that align with your specific needs. Whether you require ad-hoc data extracts, in-depth analysis and recommendations, site/investigator identification, or real-world evidence generation, we have the flexibility and resources to tailor our services to your individual goals. Our agile approach ensures that you receive actionable insights in a timely manner, empowering you to make informed decisions with confidence.

Our experts

Our data is curated by the industry’s largest team of therapeutically aligned, expert analysts, making Citeline the most trusted source of R&D intelligence on the market.

Our analysis, insight and consultancy services span drug, device, company, clinical trial and market intelligence. And because our approach is interconnected, our analysts can give a broader perspective, identifying disruptive events, and in turn, helping you spot opportunities and mitigate risk.

No other company can boast our level of expertise and we are proud to be able to pass on the benefits of the approach we take to data collection, curation and analysis to our customers.